BIOTRONIK's extensive engineering research has produced industry-leading batteries which extend the life of the Lumax 540 devices up to 10 years. "Patients could benefit from this extended battery life due to the need for fewer device replacements over time, thereby improving quality of life and at the same time helping to reduce healthcare costs. In fact, we are so confident in the advantages of our new battery technology, BIOTRONIK will further extend our warranty for our Lumax 540 ICDs", commented Marlou Janssen, Vice President Global Marketing and Sales, Cardiac Rhythm Management, BIOTRONIK. "With the Lumax 540 series BIOTRONIK has demonstrated its commitment to patients by developing the highest quality devices that offer daily protection with optimal therapy delivery for an improved quality of life and to save patients' lives."
The number of patients with cardiac devices who require follow-up has increased dramatically and is putting clinics under considerable pressures to meet these needs. The innovative set of functionalities of the Lumax 540 series help physicians efficiently and easily automate the in-office follow up of patients with BIOTRONIK devices. For the first time all essential follow up data are ready for review, print-out and automatic data storage within 20 seconds after device interrogation. The same data is also available to the physician via the BIOTRONIK Home Monitoring(R) technology for daily automatic event detection and on-demand online patient status reviews.
The Lumax 540 devices offer the unique combination of advanced
tachycardia therapy management, diagnostic capabilities and remote
|SOURCE BIOTRONIK GmbH & Co. KG|
Copyright©2008 PR Newswire.
All rights reserved